Bilateral Risk-Reducing Oophorectomy in BRCA1 and BRCA2 Mutation Carriers

By Domchek Susan M.   Stopfer Jill E.   Rebbeck Timothy R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 177-182

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

A Mutation in the 5′ Untranslated Region of the BRCA1 Gene in Sporadic Breast Cancer Causes Downregulation of Translation Efficiency

By Wang J   Lu C   Min D   Wang Z   Ma X  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 564-573

Field House Publishing

Access to resources Recommend Favorite

Hormone Responsive Breast Cancer and BRCA1 Mutation: Mechanism, Regulation and Iron-mediated Effects

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 12, 2014-12 ,pp. : 1113-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2

By Jackson Sarah A.   Davis Andrew A.   Li Jun   Yi Nengjun   McCormick Shelley R.   Grant Carly   Fallen Taya   Crawford Beth   Loranger Kate   Litton Jennifer   Arun Banu   Vande Wydeven Kimberly   Sidani Amer   Farmer Katie   Sanders Merideth   Hoskins Kent   Nussbaum Robert   Esserman Laura   Garber Judy E.   Kaklamani Virginia G.    

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1557-1564

Blackwell Publishing

Access to resources Recommend Favorite

Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer

By Liu Guoyan   Yang Da   Sun Yan   Shmulevich Ilya   Xue Fengxia   Sood Anil K   Zhang Wei  

Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. : 1523-1535

Future Medicine

Access to resources Recommend Favorite